Drug intelligence / Profile preview

Calm 750

Development stage: Unknown
Lead developer: Pillcraft
Administration: Oral

Overview

Calm 750 is an over-the-counter Ayurvedic dietary supplement developed and marketed by Pillcraft. Formulated to help manage stress, anxiety, and sleep disturbances, it contains a blend of traditional herbal ingredients including Tagar (*Valeriana wallichii*), Jatamansi (*Nardostachys jatamansi*), Brahmi (*Bacopa monnieri*), Vijaya extract (*Cannabis sativa*), and Khurasini Ajwain (*Hyoscyamus niger*). The supplement is designed to promote relaxation, enhance mental clarity, and support restful sleep without causing grogginess.

Brand names: Calm 750Calm750Calm-750
Other names: Natural Stress Relief & Sleep Support

Targets

CNR1 (Cannabinoid receptor 1)GABRR (GABA-A receptor subunit rho)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on Calm 750.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calm 750.

Explore the full profile